Optimal Oxygenation in Neonatal Lung Injury

新生儿肺损伤的最佳氧合

基本信息

项目摘要

DESCRIPTION (provided by applicant): The American Heart Association recently released guidelines recommending the use of 21% oxygen during initial resuscitation of term newborn infants and use of blended supplemental oxygen to maintain target saturations in premature infants. The American Academy of Pediatrics recommends maintaining PaO2 between 50 and 80 mmHg in the management of sick neonates. These recommendations are based on studies using oxygen saturations in human infants and through translational studies in neonatal animal models without lung disease. Optimal oxygen concentration and target oxygen saturation range during resuscitation and ventilation of preterm and term neonates with lung injury/disease from a standpoint of tissue oxygen delivery and oxygen toxicity is not known. The overall goal of oxygen therapy is to provide adequate oxygen to meet tissue demand without risking oxygen toxicity. The overarching aim of this proposal is to determine the optimal concentration of inspired oxygen during resuscitation and ventilation of a newborn lamb with parenchymal lung disease/ lung injury. Two patterns of neonatal lung injury will be studied in this proposal. In ter lambs injury will be induced by aspiration of meconium during gasping respirations induced as a consequence of umbilical cord occlusion and asphyxia ("asphyxia-MAS" group). Preterm lambs delivered at 126d gestation (term ~ 145d) have parenchymal lung injury as a consequence of surfactant deficiency and respiratory distress syndrome ("preterm-RDS" group). Lambs will be resuscitated and ventilated with 21% oxygen, 100% oxygen or adjusted inspired oxygen concentration to maintain oxygen saturations between 85 to 89%, 90 to 94% or 95 to 99%. The first specific aim of this proposal is to determine the effect inspired oxygen concentration and saturations on oxygenation, lung oxygen uptake and oxygen delivery to the tissues. The second specific aim is to evaluate the effect of oxygen concentration and saturations on pulmonary, cerebral, coronary and ductal hemodynamics and assess delivery of oxygen to various vital organs. We intend to evaluate the risk of oxidant injury in the lung and brain associated with various levels of oxygen through our last specific aim.
描述(由申请人提供):美国心脏协会最近发布了指南,建议在足月新生儿的初始复苏期间使用21%的氧气,并使用混合补充氧气来维持早产儿的目标饱和度。美国儿科学会建议在新生儿护理中将PaO 2维持在50 - 80 mmHg之间。这些建议是基于在人类婴儿中使用氧饱和度的研究和通过在无肺部疾病的新生动物模型中的转化研究。从组织氧输送和氧毒性的角度来看,患有肺损伤/疾病的早产儿和足月新生儿复苏和通气期间的最佳氧浓度和目标氧饱和度范围尚不清楚。氧疗的总体目标是提供足够的氧气以满足组织需求,而不会有氧中毒的风险。本建议的首要目标是确定在新生羔羊肺实质性肺疾病/肺损伤复苏和通气过程中吸入氧气的最佳浓度。两种模式的新生儿肺损伤将在这个建议进行研究。在三只羔羊中,由于脐带阻塞和窒息(“窒息-MAS”组),在喘息呼吸期间吸入胎粪将诱导损伤。在妊娠126天(足月~ 145天)分娩的早产羔羊由于表面活性物质缺乏和呼吸窘迫综合征(“早产-RDS”组)而具有实质性肺损伤。将对羔羊进行复苏并使用21%氧气、100%氧气或调整吸入氧气浓度进行通气,以维持氧饱和度在85 - 89%、90 - 94%或95 - 99%之间。该建议的第一个具体目的是确定吸入氧浓度和饱和度对氧合、肺氧摄取和向组织的氧输送的影响。第二个具体目标是评价氧浓度和饱和度对肺、脑、冠状动脉和导管血流动力学的影响,并评估向各种重要器官输送氧气的情况。我们打算通过我们最后一个特定的目标来评估与不同氧水平相关的肺和脑中氧化剂损伤的风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Satyanarayana Lakshminrusimha其他文献

Satyanarayana Lakshminrusimha的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Satyanarayana Lakshminrusimha', 18)}}的其他基金

Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    10734639
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    9627355
  • 财政年份:
    2012
  • 资助金额:
    $ 22.37万
  • 项目类别:
Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    8657405
  • 财政年份:
    2012
  • 资助金额:
    $ 22.37万
  • 项目类别:
Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    8334978
  • 财政年份:
    2012
  • 资助金额:
    $ 22.37万
  • 项目类别:
Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    10221747
  • 财政年份:
    2012
  • 资助金额:
    $ 22.37万
  • 项目类别:
Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    9750728
  • 财政年份:
    2012
  • 资助金额:
    $ 22.37万
  • 项目类别:
Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    9384013
  • 财政年份:
    2012
  • 资助金额:
    $ 22.37万
  • 项目类别:
Optimal Oxygenation in Neonatal Lung Injury
新生儿肺损伤的最佳氧合
  • 批准号:
    9054668
  • 财政年份:
    2012
  • 资助金额:
    $ 22.37万
  • 项目类别:
Antenatal Betamethasone in Late Preterm Gestation Lambs
晚期早产羔羊的产前倍他米松
  • 批准号:
    7572417
  • 财政年份:
    2009
  • 资助金额:
    $ 22.37万
  • 项目类别:
Antenatal Betamethasone in Late Preterm Gestation Lambs
晚期早产羔羊的产前倍他米松
  • 批准号:
    7826658
  • 财政年份:
    2009
  • 资助金额:
    $ 22.37万
  • 项目类别:

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 22.37万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 22.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了